<DOC>
	<DOCNO>NCT01715974</DOCNO>
	<brief_summary>The purpose study determine whether Assisted Reproductive Technologies treatment G-CSF , growth factor work stem cell , may improve pregnancy rate pregnancy outcome patient experience recurrent implantation failure IVF cycle .</brief_summary>
	<brief_title>Use G-CSF Treatment Recurrent Implantation Failure</brief_title>
	<detailed_description>We previously show G-CSF may useful treatment recurrent abortion . The G-CSF cytokine promote leukocyte growth , also trophoblast development . In randomized sudy investigator test cytokine treatment recurrent implantation failure IVF , leat three fail previous IVF attempt . The study conduct 100 woman recurrent implantation failure The inclusion criterion , least three previous fail IVF attempt least 8 good embryo transfer , woman le 40 year old , absence systemic disease . These woman undergo IVF cycle randomly divide two group : one ( 50 woman ) treat subcutaneous G-CSF 60 micrograms/day day transfer day β-hCG test , positive treatment continue 40 day ; group control treat subcutaneous saline solution infusion way study group . Primary outcomes consider : pregnancy rate β-hCG level 14/21/28 35 day embryo transfer .</detailed_description>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>woman 40 year old less three previous IVF cycle fail , total least 8 good embryo replace uterus chromosomal defect patient , metabolic disease ( diabetes etc . ) genetic disease ( thalassemia , cystic fibrosis , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>G-CSF , IVF failure , pregnancy</keyword>
</DOC>